The study by Sari Reisner and colleagues1 in The Lancet HIV on gender-affirming hormone therapy and its effect on HIV ...
With the 24% cuts and PEPFAR discontinued, we estimated there could be 4.43 million to 10.75 million additional HIV ...
The CDC's potential 'streamlining' of programs to prevent HIV has two Southern California health agencies worried the ...
After decades of failed attempts, scientists were optimistic that a new generation of HIV vaccine candidates would finally ...
A study published in Lancet HIV Thursday showed that patients who received gender-affirming hormones were 37% less likely to ...
Despite substantial progress towards achieving the UNAIDS 95–95–95 targets,1 the global HIV response continues to be undermined by a multitude of complex, interrelated challenges. Persistent stigma ...
A new modeling study published in The Lancet HIV journal highlights the alarming potential impact of significant reductions ...
Ethiopia's Tigray region was once considered a model in the country's fight against HIV. Years of awareness-raising efforts ...
Black women make up over 50% of new HIV cases among women in the United States, and in Atlanta alone, nearly 60% of new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback